Adiposogenital dystrophy medical therapy

Revision as of 02:14, 18 August 2021 by Nnabude (talk | contribs)
Jump to navigation Jump to search

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy medical therapy

CDC on Adiposogenital dystrophy medical therapy

Adiposogenital dystrophy medical therapy in the news

Blogs on Adiposogenital dystrophy medical therapy

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy medical therapy

Overview

The genital signs, low B.M.R., and obesity in many cases disappear during or after puberty without any treatment due to genital development and with the correction of B.M.R.. The genital under-development seen in adiposogenital dystrophy responds to injections of pregnancy urine extract follutein (Squibb).

Medical therapy

The genital under-development seen in adiposogenital dystrophy responds to injections of pregnancy urine extract follutein (Squibb)[1]

References

  1. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1210/endo-23-5-637 Check |pmid= value (help).

Template:WH Template:WS